Among the 876 oral cancer patients, only patients with the AURKA rs2064863 gene had a 1.365-fold higher risk of stage III or IV OSCC (95% CI 1.029–1.811) than did patients with the rs2064863 wild-type gene (p = 0.031). The gene discussed is AURKA; the disease is lip and oral cavity carcinoma.